RBS Morgans still have a 95 cent target.
They say that the commercial partner will be the next bit of good news to come.
They also say that the now confirmed FDA classification will probably extend the USA trials by 6 - 12 months.
HOWEVER, they also say that their target price does NOT include the USA!
Looks good going forward.
Regards...............
RBS Morgans still have a 95 cent target.They say that the...
Add to My Watchlist
What is My Watchlist?